Recurrent or locally advanced retroperitoneal soft tissue sarcoma research hub

First-in-man clinical trial to assess safety and tolerability of CEB-01 PLGA membrane in patients with recurrent or locally advanced retroperitoneal soft tissue sarcoma after surgery

This study is looking at a new type of treatment, a special membrane called CEB-01 PLGA, for people with a type of cancer called retroperitoneal soft tissue sarcoma that has come back or spread nearby after surgery. The main aim is to check if it's safe and how well people tolerate it.